
### [MONDO:0017769](http://purl.obolibrary.org/obo/MONDO_0017769)
**Label:** acquired immunodeficiency

**Subclasses:** [MONDO:0007603](http://purl.obolibrary.org/obo/MONDO_0007603) (Felty's syndrome), [MONDO:0015696](http://purl.obolibrary.org/obo/MONDO_0015696) (Good syndrome), [MONDO:0019469](http://purl.obolibrary.org/obo/MONDO_0019469) (T-cell large granular lymphocyte leukemia), [MONDO:0015822](http://purl.obolibrary.org/obo/MONDO_0015822) (acquired neutropenia), [MONDO:0018739](http://purl.obolibrary.org/obo/MONDO_0018739) (neonatal alloimmune neutropenia), [MONDO:0011922](http://purl.obolibrary.org/obo/MONDO_0011922) (adult idiopathic neutropenia), [MONDO:0017617](http://purl.obolibrary.org/obo/MONDO_0017617) (acquired adult-onset immunodeficiency), 

**Mapped go classes:** [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0007422](http://purl.obolibrary.org/obo/GO_0007422) (peripheral nervous system development), [GO:0051569](http://purl.obolibrary.org/obo/GO_0051569) (regulation of histone H3-K4 methylation), [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis), 

**Class expressions from DL-Learner:**

- [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis) 75.00%
- [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis) 75.00%
- [GO:0007422](http://purl.obolibrary.org/obo/GO_0007422) (peripheral nervous system development) 75.00%
- [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis) and [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development) 75.00%
- [GO:0030097](http://purl.obolibrary.org/obo/GO_0030097) (hemopoiesis) 60.36%
- [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development) 53.99%
- [GO:0032502](http://purl.obolibrary.org/obo/GO_0032502) (developmental process) 52.53%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 51.15%
- Thing 50.90%
- [GO:0048534](http://purl.obolibrary.org/obo/GO_0048534) (hematopoietic or lymphoid organ development) 43.90%
- [GO:0048568](http://purl.obolibrary.org/obo/GO_0048568) (embryonic organ development) 42.68%
- [GO:0048731](http://purl.obolibrary.org/obo/GO_0048731) (system development) 35.43%
- [GO:0048513](http://purl.obolibrary.org/obo/GO_0048513) (animal organ development) 31.02%
- [GO:0000047](http://purl.obolibrary.org/obo/GO_0000047) (obsolete Rieske iron-sulfur protein) 0.00%
- [GO:0000046](http://purl.obolibrary.org/obo/GO_0000046) (null) 0.00%


